Can a Single Blood Test Predict Your Recovery Path?

A Breakthrough in Predictive Diagnostics

Researchers from Imperial College London recently introduced VeloCD, a method that can predict illness trajectory from a single blood sample. This breakthrough uses RNA markers to forecast how a patient’s health might change. For instance, it can determine if a child with a fever will recover quickly or require intensive care. Additionally, the test identifies whether healthy individuals exposed to viruses like COVID-19 will actually develop symptoms. This predictive power could transform how doctors manage infectious diseases globally.

How VeloCD Can Predict Illness Trajectory

The test relies on a technique known as “RNA velocity.” Initially, scientists used this method to study individual cells. However, the research team adapted it to analyze whole blood samples effectively. By measuring the ratio of spliced and unspliced RNA, they can see if specific gene activity is increasing or decreasing. Consequently, this provides a snapshot of the body’s future response. Doctors can then use this information to prioritize high-risk patients. Furthermore, this approach reduces the need for repeated blood tests over several days.

Clinical Benefits and Applications

The study, published in Nature Communications, highlights several key applications. In pediatric cases, VeloCD successfully identified children likely to deteriorate during acute fever. To further your expertise in this field, consider exploring our specialized training for pediatricians. Moreover, in adult trials, the test predicted infection status for influenza A and SARS-CoV-2. Beyond viral infections, the researchers found potential uses in chronic conditions. For example, it could predict treatment response in inflammatory bowel disease. Because the test requires only one time-point, it offers a faster triage solution for overcrowded hospitals, which is an essential skill for professionals working in emergency medicine.

Frequently Asked Questions

Q1: What is the VeloCD blood test?

It is a diagnostic tool that analyzes RNA velocity in whole blood to predict the future course of an illness from a single sample.

Q2: How does RNA velocity work in this test?

The method measures gene expression changes to see if activity is ramping up or winding down, indicating future clinical states before they manifest.

Q3: Which diseases can this test currently predict?

Research shows it can predict trajectories for COVID-19, influenza, pediatric fever, and even treatment responses in inflammatory bowel disease.

References

1. Study describes blood test that might reveal one’s illness trajectory, responseto treatment – ETHealthworld
2. Imperial College London. (2026). Blood test could help predict disease progression and how well treatment will work.
3. Dunican, C., et al. (2026). Predicting trajectories of illness using RNA velocity of whole blood. Nature Communications.

Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.